Volunteers tolerate the Vaccine from COVID-19, their condition was not serious, said Director of the Scientific-practical center of interventional Cardioangiology sechenovskiy University Sergey Semitko.
He noticed that at the end of the month will be ready reliable results of the first phase of the clinical trial.
The vaccine was developed, the research center of epidemiology and Microbiology named after N. F. Gamalei, in a clinical trial involved 38 volunteers.
for his part, Director of the Institute of pharmacy and translational medicine sechenovskiy University Vadim Tarasov told about the features of the vaccine.
As stressed by the head of the center for clinical study of drugs sechenovskiy University Elena Smolyarchuk, Volunteers who were administered a Vaccine COVID-19, four days left the hospital, but they can always call the doctor at the slightest change of health " when they suspect that the vaccine could nevertheless affect their health."
She said that in the case of treatment, the doctors will advise volunteers and, if necessary, to provide them with medical care.
in mid-June, the Ministry of health gave permission to conduct clinical studies of 2 forms of vaccine COVID-19.
inspections are conducted at the Burdenko hospital of the defense Ministry of Russia, the same research on volunteers in the civil Sechenovskiy go to medical school.
yesterday the Ministry of defense stressed that began the final stage of clinical trials.
Current information on the situation of COVID-19 in Russia and the world presented on the portal stopmanager. Of the Russian Federation.